CA Stock MarketDetailed Quotes

AION Aion Therapeutic Inc

Watchlist
  • 0.010
  • 0.0000.00%
15min DelayMarket Closed Jan 3 15:35 ET
4.84MMarket Cap-0.53P/E (TTM)

Aion Therapeutic Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Oct 31, 2024
(Q1)Jul 31, 2024
(FY)Apr 30, 2024
(Q4)Apr 30, 2024
(Q3)Jan 31, 2024
(Q2)Oct 31, 2023
(Q1)Jul 31, 2023
(FY)Apr 30, 2023
(Q4)Apr 30, 2023
(Q3)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-238.40%-148.27K
-131.31%-544.93K
-1,941.32%-845.05K
-633.69%-808.88K
303.08%243.24K
-650.30%-43.82K
-190.31%-235.59K
96.93%-41.4K
1,205.36%151.57K
-22.17%-119.77K
Net income from continuing operations
-221.36%-582.81K
-12.85%-370.81K
-2,349.64%-6.29M
-2,487.43%-5.4M
-75.21%-377.95K
-44.42%-181.36K
-212.02%-328.58K
93.28%-256.66K
87.11%-208.67K
66.85%-215.72K
Operating gains losses
----
----
----
----
----
----
----
---563.3K
--135.19K
---136.24K
Depreciation and amortization
--28.59K
--28.68K
143.37%42.11K
21,434.13%27.13K
156.56%14.97K
--0
--0
-73.50%17.3K
-92.19%126
-66.62%5.84K
Asset impairment expenditure
----
----
916.04%2.01M
1,590.07%2.01M
----
----
----
-124.68%-246.84K
---135.19K
--0
Unrealized gains and losses of investment securities
----
----
-88.09%12.96K
----
----
----
----
--108.81K
----
----
Other non cashItems
117.91%63.73K
52.41%52.5K
1,960.19%3.02M
9,259.54%2.91M
13.84%47.75K
-24.23%29.24K
-1.85%34.45K
110.70%146.76K
7.95%31.11K
77.98%41.95K
Change In working capital
216.00%342.22K
-536.06%-255.3K
-53.59%349.26K
-270.78%-376.05K
202.84%558.47K
21.48%108.3K
-77.38%58.55K
-43.70%752.53K
-63.30%220.19K
-63.96%184.41K
-Change in receivables
-754.61%-99.93K
-111.03%-17.39K
401.20%165.34K
276.45%33.76K
-523.44%-41.37K
226.02%15.27K
1,027.01%157.68K
29.16%-54.89K
-586.30%-19.13K
69.37%-6.64K
-Change in inventory
---55.77K
---124.3K
---76.89K
---24.71K
---52.19K
--0
--0
--0
--0
----
-Change in prepaid assets
1,342.74%21.75K
---388.27K
-326.54%-17.34K
---15.59K
--0
---1.75K
--0
-96.35%7.66K
--0
-19.86%28.91K
-Change in payables and accrued expense
-167.85%-76.88K
377.09%274.68K
-65.22%278.16K
-254.40%-369.52K
290.73%633.5K
11.89%113.31K
-133.37%-99.13K
-32.61%799.77K
-43.66%239.33K
-67.39%162.13K
Cash from discontinued investing activities
Operating cash flow
-238.40%-148.27K
-131.31%-544.93K
-1,941.32%-845.05K
-633.69%-808.88K
303.08%243.24K
-650.30%-43.82K
-190.31%-235.59K
96.93%-41.4K
1,205.36%151.57K
-22.17%-119.77K
Investing cash flow
Cash flow from continuing investing activities
0
0
-314.09%-289.42K
0
-117.28%-23.36K
-201.28K
-64.78K
135.19K
0
135.19K
Net PPE purchase and sale
----
----
--0
--0
----
----
----
--135.19K
--0
----
Net other investing changes
----
----
---289.42K
--0
---23.36K
---201.28K
---64.78K
----
----
----
Cash from discontinued investing activities
Investing cash flow
--0
--0
-314.09%-289.42K
--0
-117.28%-23.36K
---201.28K
---64.78K
--135.19K
--0
--135.19K
Financing cash flow
Cash flow from continuing financing activities
-80.14%76.96K
267.13%569.05K
586.17%1.12M
61,405.93%528.95K
139.51%48.71K
124.18%387.5K
37.37%155K
-86.37%163.25K
-98.80%860
-227.38%-123.29K
Net issuance payments of debt
---165.04K
--369.05K
-96.77%2.05K
-2,509.19%-20.72K
118.46%22.76K
--0
--0
-43.07%63.25K
-98.80%860
-227.38%-123.29K
Net common stock issuance
-55.39%242K
--200K
--542.5K
--0
--0
--542.5K
--0
--0
--0
--0
Net other financing activities
----
----
475.61%575.61K
--549.67K
----
----
--155K
487.75%100K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-80.14%76.96K
267.13%569.05K
586.17%1.12M
61,405.93%528.95K
139.51%48.71K
124.18%387.5K
37.37%155K
-86.37%163.25K
-98.80%860
-227.38%-123.29K
Net cash flow
Beginning cash position
138.67%80.96K
20,238.10%68.34K
--336
--349.28K
-93.13%926
100.25%33.92K
--336
--0
--0
27.41%13.47K
Current changes in cash
-150.07%-71.31K
116.59%24.12K
-105.57%-14.31K
-283.65%-279.93K
348.97%268.58K
-21.24%142.4K
-558.84%-145.36K
271.85%257.04K
83.40%152.43K
-8,565.06%-107.88K
Effect of exchange rate changes
147.92%84.05K
-106.43%-11.5K
132.06%82.31K
99.33%-1.02K
-15.50%79.77K
4.82%-175.4K
1,313.93%178.95K
-184.40%-256.7K
-79.00%-152.09K
1,362.62%94.41K
End cash Position
10,018.25%93.7K
138.67%80.96K
20,238.10%68.34K
20,238.10%68.34K
--349.28K
-93.13%926
100.25%33.92K
--336
--336
--0
Free cash from
-238.40%-148.27K
-131.31%-544.93K
-1,941.32%-845.05K
-633.69%-808.88K
303.08%243.24K
-650.30%-43.82K
-190.31%-235.59K
96.93%-41.4K
1,205.36%151.57K
-22.17%-119.77K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Oct 31, 2024(Q1)Jul 31, 2024(FY)Apr 30, 2024(Q4)Apr 30, 2024(Q3)Jan 31, 2024(Q2)Oct 31, 2023(Q1)Jul 31, 2023(FY)Apr 30, 2023(Q4)Apr 30, 2023(Q3)Jan 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -238.40%-148.27K-131.31%-544.93K-1,941.32%-845.05K-633.69%-808.88K303.08%243.24K-650.30%-43.82K-190.31%-235.59K96.93%-41.4K1,205.36%151.57K-22.17%-119.77K
Net income from continuing operations -221.36%-582.81K-12.85%-370.81K-2,349.64%-6.29M-2,487.43%-5.4M-75.21%-377.95K-44.42%-181.36K-212.02%-328.58K93.28%-256.66K87.11%-208.67K66.85%-215.72K
Operating gains losses -------------------------------563.3K--135.19K---136.24K
Depreciation and amortization --28.59K--28.68K143.37%42.11K21,434.13%27.13K156.56%14.97K--0--0-73.50%17.3K-92.19%126-66.62%5.84K
Asset impairment expenditure --------916.04%2.01M1,590.07%2.01M-------------124.68%-246.84K---135.19K--0
Unrealized gains and losses of investment securities ---------88.09%12.96K------------------108.81K--------
Other non cashItems 117.91%63.73K52.41%52.5K1,960.19%3.02M9,259.54%2.91M13.84%47.75K-24.23%29.24K-1.85%34.45K110.70%146.76K7.95%31.11K77.98%41.95K
Change In working capital 216.00%342.22K-536.06%-255.3K-53.59%349.26K-270.78%-376.05K202.84%558.47K21.48%108.3K-77.38%58.55K-43.70%752.53K-63.30%220.19K-63.96%184.41K
-Change in receivables -754.61%-99.93K-111.03%-17.39K401.20%165.34K276.45%33.76K-523.44%-41.37K226.02%15.27K1,027.01%157.68K29.16%-54.89K-586.30%-19.13K69.37%-6.64K
-Change in inventory ---55.77K---124.3K---76.89K---24.71K---52.19K--0--0--0--0----
-Change in prepaid assets 1,342.74%21.75K---388.27K-326.54%-17.34K---15.59K--0---1.75K--0-96.35%7.66K--0-19.86%28.91K
-Change in payables and accrued expense -167.85%-76.88K377.09%274.68K-65.22%278.16K-254.40%-369.52K290.73%633.5K11.89%113.31K-133.37%-99.13K-32.61%799.77K-43.66%239.33K-67.39%162.13K
Cash from discontinued investing activities
Operating cash flow -238.40%-148.27K-131.31%-544.93K-1,941.32%-845.05K-633.69%-808.88K303.08%243.24K-650.30%-43.82K-190.31%-235.59K96.93%-41.4K1,205.36%151.57K-22.17%-119.77K
Investing cash flow
Cash flow from continuing investing activities 00-314.09%-289.42K0-117.28%-23.36K-201.28K-64.78K135.19K0135.19K
Net PPE purchase and sale ----------0--0--------------135.19K--0----
Net other investing changes -----------289.42K--0---23.36K---201.28K---64.78K------------
Cash from discontinued investing activities
Investing cash flow --0--0-314.09%-289.42K--0-117.28%-23.36K---201.28K---64.78K--135.19K--0--135.19K
Financing cash flow
Cash flow from continuing financing activities -80.14%76.96K267.13%569.05K586.17%1.12M61,405.93%528.95K139.51%48.71K124.18%387.5K37.37%155K-86.37%163.25K-98.80%860-227.38%-123.29K
Net issuance payments of debt ---165.04K--369.05K-96.77%2.05K-2,509.19%-20.72K118.46%22.76K--0--0-43.07%63.25K-98.80%860-227.38%-123.29K
Net common stock issuance -55.39%242K--200K--542.5K--0--0--542.5K--0--0--0--0
Net other financing activities --------475.61%575.61K--549.67K----------155K487.75%100K--0--0
Cash from discontinued financing activities
Financing cash flow -80.14%76.96K267.13%569.05K586.17%1.12M61,405.93%528.95K139.51%48.71K124.18%387.5K37.37%155K-86.37%163.25K-98.80%860-227.38%-123.29K
Net cash flow
Beginning cash position 138.67%80.96K20,238.10%68.34K--336--349.28K-93.13%926100.25%33.92K--336--0--027.41%13.47K
Current changes in cash -150.07%-71.31K116.59%24.12K-105.57%-14.31K-283.65%-279.93K348.97%268.58K-21.24%142.4K-558.84%-145.36K271.85%257.04K83.40%152.43K-8,565.06%-107.88K
Effect of exchange rate changes 147.92%84.05K-106.43%-11.5K132.06%82.31K99.33%-1.02K-15.50%79.77K4.82%-175.4K1,313.93%178.95K-184.40%-256.7K-79.00%-152.09K1,362.62%94.41K
End cash Position 10,018.25%93.7K138.67%80.96K20,238.10%68.34K20,238.10%68.34K--349.28K-93.13%926100.25%33.92K--336--336--0
Free cash from -238.40%-148.27K-131.31%-544.93K-1,941.32%-845.05K-633.69%-808.88K303.08%243.24K-650.30%-43.82K-190.31%-235.59K96.93%-41.4K1,205.36%151.57K-22.17%-119.77K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data